Posted inMarket
Legend Biotech Stock Maintained at Buy by H.C. Wainwright
H.C. Wainwright maintains its buy rating for Legend Biotech, highlighting strong market positioning and ongoing growth potential.
Posted inMarket
H.C. Wainwright Reaffirms Buy Rating for Milestone Pharmaceuticals Following Regulatory Nod in China
H.C. Wainwright maintains its Buy rating for Milestone Pharmaceuticals following a significant regulatory approval in China.
